Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FA0R6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,657
Award facts
- Contract value 100% obligated
- $17,657.23 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $17.66K delivery order to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300 mg pen injections. This is a firm fixed-price, non-set-aside contract with a completion date of December 24, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement across military and veteran healthcare systems. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99M global pharmaceutical support vehicle valued through December 2026.
Cosentyx is a specialty immunosuppressant medication used to treat autoimmune conditions such as psoriasis, psoriatic arthritis, and ankylosing spondylitis. This delivery order fulfills a portion of medical supply needs through the DLA's comprehensive pharmaceutical prime vendor program, which leverages AmerisourceBergen's extensive portfolio of brand-name and generic pharmaceuticals, vaccines, and medical devices to support Defense Health Agency operations and other federal healthcare systems. The non-competitive nature of delivery orders under existing IDCs allows for efficient procurement of critical medications needed by military medical facilities.
Quick answers
Who was awarded contract SPE2DR26FA0R6?
SPE2DR26FA0R6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 23, 2025.
How much is contract SPE2DR26FA0R6 worth?
The government has obligated $17,657 on SPE2DR26FA0R6.
Is contract SPE2DR26FA0R6 an order under another contract?
Yes. SPE2DR26FA0R6 is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FA0R6 competed?
The extent of competition for SPE2DR26FA0R6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award